BELSOMRA
suvorexant
- Strength
- 10 mg/1
- Form
- Tablet, Film Coated
- Class
- Orexin Receptor Antagonist
Merck Sharp & Dohme LLC
Not stocked by us — reference only
suvorexant
Listed by Merck Sharp & Dohme LLC
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Orexin Receptor Antagonist |
| Approval route | NDA — original brand approval |
| NDC code | 0006-0335 |
| FDA application | NDA204569 |
| RxNorm concept | 1547104 |
| Package sizes listed | 2 |
| Marketed since | August 2014 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
suvorexant
Merck Sharp & Dohme LLC
Not stocked by us — reference only
suvorexant
Merck Sharp & Dohme LLC
Not stocked by us — reference only
suvorexant
Merck Sharp & Dohme LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.